Pharmafile Logo
Pharmafocus logo
Advanced Search

vorapaxar

Showing 6 posts of 6 posts found.

Merck image

Merck’s vorapaxar gains long-awaited FDA approval

May 9, 2014
Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …

News
Merck image

Reprieve for Merck’s vorapaxar

January 16, 2014
Sales and Marketing FDA, Merck, heart, vorapaxar

An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …

News

Fate of Merck’s vorapaxar still unclear

February 8, 2012
Medical Communications, Sales and Marketing Merck, vorapaxar

Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …

News

Merck’s vorapaxar fails in late-stage trial

November 15, 2011
ACS, Brilinta, Efient, Merck, Plavix, antiplatelet, vorapaxar

Merck’s novel blood thinner vorapaxar has failed to meet its primary endpoint in a late-stage study.The TRACER trial compared vorapaxar …

News

Merck drops oral anticoagulant

March 25, 2011
Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar

Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …

News

Merck suffers late-stage blow to vorapaxar

January 18, 2011
Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar

An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025